Switzerland authorises use of Moderna coronavirus vaccine for children aged six to eleven
Moderna Inc said on Friday Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years. The approval is for the vaccine’s two-dose series of 50 micro gram per dose, Moderna added.